Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
월요일, 8월 31

Amgen Inc

AMGNNASDAQ
Trade with Public
Trade with Public
$429.88
-2.54-0.59%
가까이에: Aug 31, 5:00 PM EST
$429.88
N/A
시간외: 4:02 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황배당금비교옵션주식 보고서

Amgen Financials

Amgen (AMGN) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Amgen Narrows FY2026 GAAP EPS Guidance from $15.62-$17.10 to $15.80-$17.08 vs $15.44 Est

Amgen (NASDAQ:AMGN) narrows FY2026 GAAP EPS guidance from $15.62-$17.10 to $15.80-$17.08 vs $15.44 analyst estimate..
Benzinga Newsdesk

PRO
Amgen Raises FY2026 Adj EPS Guidance from $21.70-$23.10 to $22.30-$23.50 vs $22.35 Est; Raises FY2026 Sales Guidance from $37.100B-$38.500B to $38.200B-$39.400B vs $37.741B Est

Amgen (NASDAQ:AMGN) raises FY2026 Adj EPS guidance from $21.70-$23.10 to $22.30-$23.50 vs $22.35 analyst estimate. Raises FY2026 sales outlook from $37.100 billion-$38.500 billion to $38.200 billion-$39.400 billion vs
Benzinga Newsdesk

PRO
Amgen Q2 Adj. EPS $6.29 Beats $5.62 Estimate, Sales $10.054B Beat $9.421B Estimate

Amgen (NASDAQ:AMGN) reported quarterly earnings of $6.29 per share which beat the analyst consensus estimate of $5.62 by 11.92 percent. This is a 4.49 percent increase over earnings of $6.02 per share from the same
Benzinga Newsdesk

PRO
Update: Amgen Raises FY2026 Adj EPS Guidance from $21.60-$23.00 to $21.70-$23.10 vs $22.33 Est; Raises FY2026 Sales Guidance from $37.000B-$38.400B to $37.100B-$38.500B vs $37.807B Est

Amgen (NASDAQ:AMGN) raises FY2026 Adj EPS guidance from $21.60-$23.00 to $21.70-$23.10 vs $22.33 analyst estimate. Raises FY2026 sales outlook from $37.000 billion-$38.400 billion to $37.100 billion-$38.500 billion vs
Benzinga Newsdesk

PRO
Amgen Raises FY2026 Adj EPS Guidance from $21.60-$23.00 to $21.70-$23.10 vs $22.33 Est

Amgen (NASDAQ:AMGN) raises FY2026 Adj EPS guidance from $21.60-$23.00 to $21.70-$23.10 vs $22.33 analyst estimate..
Benzinga Newsdesk

PRO
Amgen Raises FY2026 GAAP EPS Guidance from $15.45-$16.94 to $15.62-$17.10 vs $15.18 Est

Amgen (NASDAQ:AMGN) raises FY2026 GAAP EPS guidance from $15.45-$16.94 to $15.62-$17.10 vs $15.18 analyst estimate..
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved